FERRARA PIETRO

Geraci, G., Paternò, V., Vitello, A., Maida, M., Bonomo, F., Sanfilippo, S., et al. (2026). Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction–associated steatotic liver disease. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-026-02908-1]. Detail

Oh, J., Kim, S., Yim, Y., Kim, M., Zyoud, S., Zyoud, S., et al. (2026). Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study. NATURE MEDICINE, 32(1), 197-223 [10.1038/s41591-025-04077-9]. Detail

Sirota, S., Bender, R., Dominguez, R., Movo, A., Swetschinski, L., Araki, D., et al. (2026). Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. THE LANCET INFECTIOUS DISEASES, 26(4), 343-361 [10.1016/S1473-3099(25)00689-9]. Detail

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Detail

Zamagni, G., Armocida, B., Castelpietra, G., Conti, S., Cortesi, P., Ferrara, P., et al. (2026). Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 67-77 [10.19191/EP26.1.A991.020]. Detail